N
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.
Investor insights
Funding rounds participated in
$110M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2018
Funding rounds raised
Total raised
$110M
from 3 investors over 1 rounds
N
Neogene Therapeutics raised $110M on October 14, 2020
Investors: EcoR1 Capital, Jeito Capital and + 7 Other investors